The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study
Open accessAbstract
Background —Standard treatment of inoperable hepatocellular carcinoma has not been established. Somatostatin has been shown to possess antimitotic activity against a variety of non-endocrine tumours. Aims —To assess the presence of somatostatin receptors in human liver and to treat advanced hepatocellular carcinoma with the somatostatin analogue, octreotide. Methods —Somatostatin receptors were measured in liver tissue homogenates from patients with acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Fifty eight patients with advanced hepatocellular carcinoma were randomised to receive either subcutaneous octreotide 250 μg twice daily, or no treatment. Groups were comparable with respect to age, sex, Okuda classification, presence of cirrhosis, and liver biochemistry and virology. Results —Various amounts of somatostatin receptors were identified in liver tissue of all patients including those with hepatocellular carcinoma. Treated patients had an increased median survival (13 months versus four months, p=0.002, log rank test) and an increased cumulative survival rate at six and 12 months (75% versus 37%, and 56% versus 13% respectively). Octreotide administration significantly reduced α fetoprotein levels at six months. When a multivariable Cox’s proportional hazards model was fitted, variables associated with increased survival were: treatment administration, absence of cirrhosis, increased serum albumin, and small tumours. Treated patients clearly had a lower hazard (0.383) in the multivariate analysis. Conclusions —Octreotide administration significantly improves survival and is a valuable alternative in the treatment of inoperable hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
Statistical Methods in Medical Research
Lachenbruch, P. A. (1972) · Technometrics · doi:10.1080/00401706.1972.10488903 · Cited by 1,703
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
LAMBERTS, S. W. J., KRENNING, E. P., & REUBI, J.-C. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-450 · Cited by 805
Ganesan, P., & Kulik, L. M. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.08.004 · Cited by 478
Krenning, E. P., Bakker, W., Kooij, P. P. M., Breeman, W. A., Oei, H. Y., de Jong, M., Reubi, J. C., Visser, T. J., Bruns, C., & Kwekkeboom, D. J. (1992) · PubMed · Cited by 420
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).
Patel, Y. C., & Srikant, C. B. (1994) · Endocrinology · doi:10.1210/endo.135.6.7988476 · Cited by 348
Kubota, A., Yamada, Y., Kagimoto, S., Shimatsu, A., Imamura, M., Tsuda, K., Imura, H., Seino, S., & Seino, Y. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117090 · Cited by 269
Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
Bruno, J. F. (1993) · Endocrinology · doi:10.1210/en.133.6.2561 · Cited by 261
All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl Cyclase
Patel, Y. C., Greenwood, M. T., Warszynska, A., Panetta, R., & Srikant, C. B. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1088 · Cited by 239
Distribution of somatostatin receptors in normal and tumor tissue
Reubi, J. C., Kvols, L., Krenning, E., & Lamberts, S. W. J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90217-z · Cited by 234
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.724 · Cited by 190
The Analysis of Repeated Measures: A Practical Review with Examples
Everitt, B. J. (1995) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348622 · Cited by 137
Bronowicki, J., Boudjéma, K., Choné, L., Nisand, G., Bazin, C., Pflumio, F., Uhl, G., Wenger, J.-J., Jaeck, D., Boissel, P., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80007-9 · Cited by 100
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5)
Patel, Y. (1994) · Endocrinology · doi:10.1210/en.135.6.2814 · Cited by 95
Effects of somatostatin on renal function in cirrhosis
Ginés, À., Salmerón, J. M., Ginès, P., Jiménez, W., Saló, J., Piera, C., Clària, J., Rivera, F., Arroyo, V., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91446-b · Cited by 51
Somatostatin receptor-dependent growth inhibition of liver metastases by octreotide
van Eijck, C. H. J., Slooter, G. D., Hofland, L. J., Kort, W. J., Jeekel, J. J., Lamberts, S. W. J., & Marquet, R. L. (1994) · British journal of surgery · doi:10.1002/bjs.1800810925 · Cited by 24
Walsh (1995) · doi:10.1002/1097-0142(19951201)76:11
Cited by
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Metadata
- Authors
- Kouroumalis, E., Skordilis, P., Thermos, K., Vasilaki, A., Moschandrea, J., & Manousos, O. N.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1998-03-01
- Volume
- 42
- Issue
- 3
- Pages
- 442-447
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2081720784
- Cited by
- 280
- References
- 24
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.